EBS
Emergent BioSolu (EBS)
NYSE
$7.30+$0.04 (+0.48%)
Price as of Jul 24, 2026 7:34 PM EDT
  • $374.6M
    Market Cap
  • 1.26%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 63
Valuation
EBS
vs History
vs S&P 500
Profitability
0
Growth
0
Low Earnings Volatility
0

Momentum Score

Score: 53
Valuation
EBS
vs History
vs S&P 500
3-Month Momentum
5.38%
12-Month Momentum
12.85%
3-Month Risk Adjusted Momentum
23.27%
12-Month Risk Adjusted Momentum
16.03%

True Yield

N/A
Valuation
EBS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
4.20%
Net Debt Paydown Yield
-0.33%

Financial Health Score

Score: 54
Valuation
EBS
vs History
vs S&P 500
Ohlson's O-Score
6